OpGen
OPGN
#9255
Rank
โ‚น9.04 B
Marketcap
โ‚น898.36
Share price
11.11%
Change (1 day)
647.07%
Change (1 year)

P/E ratio for OpGen (OPGN)

P/E ratio as of December 2025 (TTM): -2.37

According to OpGen 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.36855. At the end of 2022 the company had a P/E ratio of -0.1841.

P/E ratio history for OpGen from 2015 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2022-0.1841-77.91%
2021-0.8333-28.1%
2020-1.161516.57%
2019-0.0717-87.18%
2018-0.559532.04%
2017-0.4237-61.23%
2016-1.09

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Enzo Biochem
ENZB
-3.33 40.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-7.34 209.98%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.